<?xml version="1.0" encoding="UTF-8"?>
<ref id="B48-ijms-22-00634">
 <label>48.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>K.-F.</given-names>
   </name>
   <name>
    <surname>Tung</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Teng</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Shen</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Hsieh</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Induction apoptosis of erinacine A in human colorectal cancer cells involving the expression of TNFR, Fas, and Fas ligand via the JNK/p300/p50 signaling pathway with histone acetylation</article-title>
  <source>Front. Pharmacol.</source>
  <year>2019</year>
  <volume>10</volume>
  <fpage>1174</fpage>
  <pub-id pub-id-type="doi">10.3389/fphar.2019.01174</pub-id>
  <pub-id pub-id-type="pmid">31680958</pub-id>
 </element-citation>
</ref>
